The effect of different blood groups on visual evoked potentials
DOI:
https://doi.org/10.15584/ejcem.2023.3.25Keywords:
blood groups, visual evoked potential, Rh factorAbstract
Introduction and aim. Purpose of the study is to determine whether it is required to use different standards when evaluating visual evoked potential (VEP) measurements of healthy individuals with different blood groups.
Material and methods. The study consisted of healthy individuals with different blood groups who have applied to the ophthalmology and neurology outpatient clinic of Düzce University Medical Faculty from January to December 2022. The patients went through detailed ophthalmologic examination and VEP test and only the ones with normal results were included to the study.
Results. The study consisted of 119 individuals, with a blood group distribution of 30 A, 29 B, 30 AB and 30 O. VEP latency and amplitude changes were compared and no significant difference was observed within 4 groups in terms of P100 and N70 latency and amplitudes. There was N70 latency prolongation in Rh- group and this difference was found to be statistically significant (p=0.009). Rh+ group was found to be high in terms of P100 amplitudes and this was considered statistically significant (both p=0.023).
Conclusion. There was no statistically significant difference in the VEP parameters of the individuals with the ABO blood groups hence same VEP normal values can be used for ABO blood groups.
Downloads
References
Pisk SV, Vuk T, Ivezić E, Jukić I, Bingulac-Popović J, Filipčić I. ABO blood groups and psychiatric disorders: a Croatian study. Blood Transfus. 2019;17(1):66. doi: 10.2450/2018.0266-17
Wang Y, Zhou BY, Zhu CG, et al. Distribution of ABO blood groups and coronary artery calcium. Heart Lung Circ. 2017;26(6):593-598. doi: 10.1016/j.hlc.2016.10.014
Shim HJ, Lee R, Shin MH, et al. Association between ABO genotype and risk of hepatocellular carcinoma in Koreans. Asian Pac J Cancer Prev. 2015;16(7):2771-2775. doi: 10.7314/apjcp.2015.16.7.2771
Pourafkari L, Ghaffari S, Ahmadi M, Tajlil A, Nader ND. Association of ABO blood types with the risk of in-stent restenosis. Perfusion. 2015;30(6):507-513. doi: 10.1177/0267659115573098
Franchini M, Favaloro EJ, Targher G, Lippi G. ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci. 2012;49(4):137-149. doi: 10.3109/10408363.2012.708647
Teberik K, Eski MT. Association of ABO blood groups and Rh factor with retinal and choroidal thickness. Eur J Ophthalmol. 2019;29(2):234-238. doi: 10.1177/1120672118783629
Tamcelik N. Ocular Electrophysıology. 2011th ed. Istanbul: Turkish Ophthalmological Association Education Publications; 2011.
Chan JH, Dua HS, Powell-Richards A, Jones DRE, Harris IM. Effect of ABO blood group mismatching on corneal epithelial cells: an in vitro study. Br J Ophthalmol. 2001;85(9):1104-1109. doi: 10.1136/bjo.85.9.1104
Naderan M, Rajabi MT, Shoar S, et al. Distribution of ABO and Rh Blood Groups in Patients With Keratoconus: A Case–Control Study. Eye & Contact Lens. 2015;41(4):214-217. doi: 10.1097/ICL.0000000000000098
Ardjomand N, Komericki P, Klein A, Mattes D, El-Shabrawi Y, Radner H. AB0 blood group expression in corneal allograft failures. Ophthalmologe 2005;102:981-986. doi: 10.1007/s00347-005-1199-1
Khan MI, Micheal S, Akhtar F, Naveed A, Ahmed A, Qamar R. Association of ABO blood groups with glaucoma in the Pakistani population. Can J Ophthalmol. 2009;44(5):582-586. doi: 10.3129/i09-104
Dua HS, Chan J, Gomes JAP, Azuara-Blanco A. Adverse effect of blood group ABO mismatching on corneal epithelial cells. Lancet. 1998;352(9141):1677-1677. doi: 10.1016/s0140-6736(05)61448-1
Englisch C, Moik F, Nopp S, Raderer M, Pabinger I, Ay C. ABO blood group type and risk of venous thromboembolism in patients with cancer. Blood Adv. 2022;6(24):6274-6281. doi: 10.1182/bloodadvances.2021006283
Cote DJ, Downer MK, Zoltick ES, Smith TR, Stampfer MJ. ABO blood group and risk of glioma. Neuro Oncol. 2017;19(6):871-873. doi: 10.1093/neuonc/nox013
Lotz RC, Welter C da S, Ramos SA, Ferreira LE, Cabral NL, FRANÇA PHC de. ABO blood group system and occurrence of ischemic stroke. Arq Neuropsiquiatr. 2021;79:1070-1075. doi: 10.1590/0004-282X-ANP-2020-0219
Dentali F, Sironi AP, Ageno W, Crestani S, Franchini M. ABO blood group and vascular disease: an update. In: Semin Thromb Hemost. Thieme Medical Publishers; 2013:049-059. doi: 10.1055/s-0033-1363460
Huang X, Zou Y, Li L, Chen S, Hou J, Yu B. Relation of ABO blood groups to the plaque characteristic of coronary atherosclerosis. Biomed Res Int. 2017;2017:2674726. doi: 10.1155/2017/2674726
Richards O, Cromie KJ, Akhunbay-Fudge C, et al. ABO blood group in aneurysmal subarachnoid haemorrhage—a pilot study. Acta Neurochir (Wien). 2022;164(2):507-515. doi: 10.1007/s00701-021-05079-5
Kumarguru BN, Pallavi P, Manjunath GV, Vasan TS, Rajalakshmi BR. Histopathological study of central nervous system lesions: emphasizing association of neoplasms with ABO blood groups. J Clin Diagn Res. JCDR. 2017;11(4):EC15. doi: 10.7860/JCDR/2017/23863.9644
Simoni AH, Jerwiarz A, Randers A, Gazerani P. Association between ABO blood types and pain perception. Somatosens Mot Res. 2017;34(4):258-264. doi: 10.1080/08990220.2018.1425675
Yang Y, Hood LJ, McPherson B. Association between ABO blood group status and cochlear/neural function: auditory brainstem response findings. Acta Otolaryngol. 2021;141(3):273-278. doi: 10.1080/00016489.2020.1858236
Smith DV, Klevitsky R, Akeson RA, Shipley MT. Taste bud expression of human blood group antigens. J Comp Neurol. 1994;343(1):130-142. doi: 10.1002/cne.903430110
Leske MC, Nemesure BB, He Q, Mendell N, Polednak A. Open-angle glaucoma and blood groups: the Barbados Eye Study. Arch Ophthalmol. 1996;114(2):205-210. doi: 10.1001/archopht.1996.01100130199017
Padma T, Murty JS. Association of genetic markers with some eye diseases. Acta Anthropogenet. 1983;7(1):1-12.
Garg MP, Pahwa JM. Primary glaucoma and blood groups. Indian J Ophthalmol. 1965;13(4):127.
Lavinsky J, Gus PI, Ehlers JA, Roehe D, Nora DB. Visual-evoked potentials: assessment of retrobulbar and peribulbar anesthesia. J Cataract Refract Surg. 2000;26(10):1529-1532. doi: 10.1016/s0886-3350(00)00447-8
Eski MT, Teberik K, Sezer T, Ayasli AH, Ozturk A. Visual evoked potential changes following Botox administration in patients with blepharospasm. Int Ophthalmol. 2023:43(6):2101-2107. doi: 10.1007/s10792-023-02639-9
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
